U.S. Life Sciences Stock News

NIO Inc. reported in early January that it achieved record deliveries in December 2025, the fourth quarter, and the full year, reaching 48,135 vehicles for the month, 124,807 for the quarter, and 326,028 for 2025, bringing cumulative deliveries to 997,592 by year-end. The breakdown across its three brands, premium NIO, family-focused ONVO, and small high-end FIREFLY, highlights how its multi-brand approach is broadening its customer base and supporting this surge in volumes. Next, we’ll...

American Airlines Group (AAL) is back in focus after Susquehanna shifted its rating to Positive, joining several large banks that have recently taken a more constructive view on the carrier. See our latest analysis for American Airlines Group. The upgrade comes after a strong run in the share price, with a 90 day share price return of 31.26% and a 30 day share price return of 6.95%, even though the 1 year total shareholder return is still 9.09% lower. That pattern suggests momentum in the...

If you are wondering whether Summit Therapeutics at US$19.68 is starting to look expensive or still offers value, you are not alone. The stock has had a strong run, with returns of 12.8% over the last 7 days, 12.0% over the last 30 days, 12.3% year to date, 8.3% over 1 year and about 3x over 3 years. The 5 year return sits at 271.3%. Recent attention on Summit Therapeutics has been driven by ongoing interest in its pipeline and partnerships within the pharmaceuticals and biotech space. This...

Why Goldman Sachs Group (GS) Is On Investors’ Radar Today Goldman Sachs Group (GS) is drawing attention after recent share price moves, with the stock last closing at $949.55. That level, together with its recent returns, is prompting closer scrutiny from investors. See our latest analysis for Goldman Sachs Group. The recent move to a US$949.55 share price comes after a 6.94% 1 month share price return and a 23.20% 3 month share price return, while the 1 year total shareholder return of...

International Business Machines (IBM) is back in focus after a recent daily move of 2.6%, with the stock closing at $312.18. That shift prompts a closer look at how the shares have been behaving lately. See our latest analysis for International Business Machines. That latest 2.6% daily share price move sits within a broader pattern, with a 7 day share price return of 5.83% and a 90 day share price return of 13.05%. The 1 year total shareholder return of 47.31% and 5 year total shareholder...

T. Rowe Price Group (TROW) is in focus after recent share price moves, with the stock last closing at $106.84. Investors are weighing this price against its fundamentals and its value score of 5. See our latest analysis for T. Rowe Price Group. Recent trading has been relatively steady, with a 1-month share price return of 1.85% and a year to date share price return of 2.11%. The 1-year total shareholder return of 1.70% contrasts with a weaker 5-year total shareholder return of a 14.95%...

If you are wondering whether Raymond James Financial’s recent share price still leaves room for value, this article walks through what the numbers actually say about the stock. The shares last closed at US$170.89, with returns of 2.1% over the past week, 4.3% over the last 30 days, 4.5% year to date, 12.3% over one year, 54.6% over three years and 167.2% over five years. Recent coverage of Raymond James Financial has focused on its role as a diversified financial services firm on the NYSE...

Riot Platforms (RIOT) is drawing attention after accelerating its shift toward AI focused data centers, funded in part by December sales of 1,818 Bitcoin that generated about US$161.6 million in net proceeds. See our latest analysis for Riot Platforms. The recent 7.38% 1 day and 11.22% 7 day share price returns, with the stock now at US$16.45, suggest interest is building again after a 25.87% 90 day share price decline. At the same time, the 39.76% 1 year total shareholder return and 173.26%...

Nebius Group recently announced plans to deploy NVIDIA’s Rubin platform across its Nebius AI Cloud and Nebius Token Factory in US and European data centers from the second half of 2026, expanding support for complex agentic and mixture-of-experts AI workloads alongside existing Blackwell- and Grace-based capacity. This move, combined with Nebius’ multibillion-dollar contracts with Microsoft and Meta and fully booked data center capacity, underlines how the company is tying next-generation...

Why the Tura launch matters for Teledyne Technologies stock Teledyne Technologies (TDY) recently drew attention after Teledyne FLIR OEM introduced Tura, an Automotive Safety Integrity Level B thermal longwave infrared camera aimed at night vision, ADAS, and autonomous vehicle applications. The camera is designed for all weather conditions and supports U.S. safety regulations such as NHTSA's FMVSS No. 127, which may influence how investors view Teledyne's role in automotive safety...

Five Below (FIVE) has been drawing attention after a period of strong recent share price moves, with the stock showing double digit returns over the past month and over the past 3 months. See our latest analysis for Five Below. Zooming out, the recent share price strength sits alongside a 1 year total shareholder return of 103.81% and a 3 year total shareholder return of 6.97%. This suggests that momentum currently looks to be building from a relatively modest medium term base. If Five...

In early January 2026, Tilray Brands, Inc. reported past fiscal Q2 2026 results showing sales of US$217.51 million and a reduced net loss of US$44.93 million compared with the prior year, alongside lower basic and diluted loss per share from continuing operations. At the same time, Tilray pushed further into mindful and alcohol-free drinking trends with new hemp-derived THC cocktails, zero-proof spirits, and cannabis-infused beverages across the U.S. and Canada, aiming to tap into growing...

GE Vernova (GEV) is drawing attention after its recent share price move, with a 2.8% gain over the past day contrasting with a negative month and past 3 months, prompting closer scrutiny from investors. See our latest analysis for GE Vernova. Even after a 2.8% 1 day share price gain to US$639.77, the 7 day and year to date share price returns of 6.0% and 5.9% declines suggest momentum has cooled. However, the 1 year total shareholder return of 74.8% remains strong. If GE Vernova has you...

In January 2026, QXO, Inc. agreed to issue up to 114,500 Series C Convertible Perpetual Preferred Shares at US$10,000 each, raising up to US$1.15 billion from investors including Apollo-affiliated AP Quince Holdings and Franklin Advisers, with a 4.75% annual dividend and conversion option at US$23.25 per share. The deal, expected to close in July 2026 and subject to transfer restrictions until April 2027, adds substantial, flexible capital that QXO has flagged as potential firepower for...

In early January 2026, Evercore announced the hiring of veteran banker Chris Macios as a senior managing director in its Financial Sponsors group in New York, while also hosting its 2nd Annual Shopping Center REIT Symposium. This combination of high-profile talent expansion and sector-focused client engagement highlights Evercore’s push to deepen sponsor relationships and specialized real estate advisory capabilities. Next, we’ll examine how the addition of Chris Macios could influence...

In recent months, Chinese regulators launched an antitrust review into competition practices in the food delivery sector, scrutinizing subsidy-driven price wars among major platforms including JD.com. This clampdown on aggressive discounting could ease pressure on JD.com’s margins, intersecting with the company’s broader push into food delivery and logistics-heavy services. We will now examine how this antitrust probe into food delivery subsidies may reshape JD.com’s investment narrative...

With no single headline driving attention today, UnitedHealth Group (UNH) sits in focus as investors weigh its recent share performance against a large, diversified health care business that spans insurance, pharmacy services, and data driven health solutions. See our latest analysis for UnitedHealth Group. Recent trading has been subdued, with a 1 day share price decline of 1.01% to US$340.51 and a 90 day share price decline of 5.40%, while the 1 year total shareholder return decline of...

Owens Corning (OC) has come into focus after a recent shift in earnings estimates and a cautious tone from analysts, even as several firms keep positive recommendations in place for the building products company. See our latest analysis for Owens Corning. The recent 8.22% 7 day share price return and 6.03% 30 day share price return at a last close of US$123 sit against a 25.81% total shareholder return decline over one year and a 61.42% total shareholder return gain over five years. This...

In its recently reported third quarter of fiscal 2026, Constellation Brands posted lower year-on-year sales and earnings, yet still exceeded analyst expectations and reaffirmed its full-year outlook while continuing dividends and share repurchases. Despite pressures on beer volumes and softer spending by key Hispanic consumers, the company preserved strong beer margins and highlighted steady demand for core brands like Corona and Modelo Especial, underlining the resilience of its portfolio...

Earlier this month, SES AI Corporation presented at CES 2026 in Las Vegas and the Gordon Research Conference on Electrochemistry in Ventura, highlighting its latest advances in AI-enhanced battery technology. By sharing its electrochemistry research and AI-driven materials work on such high-profile stages, SES AI is potentially reinforcing its positioning with both technology partners and prospective enterprise users of its Molecular Universe platform. Next, we’ll explore how SES AI’s...

Recent commentary from major banks, including a downgrade of Nucor (NUE) by Morgan Stanley, alongside increased confidence in its prospects, has pushed the stock into focus for investors weighing steel sector exposure. See our latest analysis for Nucor. At a share price of US$165.97, Nucor has recently seen a 1 day share price return of 1.34% and a 90 day share price return of 19.83%, while its 1 year total shareholder return of 37.27% and 5 year total shareholder return of 223.44% point to...

MGIC Investment (MTG) has been drawing attention after recent share price swings, with the stock down about 4% over the past month but modestly positive over the past 3 months. See our latest analysis for MGIC Investment. Zooming out, MGIC Investment’s recent 1 month share price return of around a 4% decline and a softer 7 day move sit against a 1 year total shareholder return of 22.94%. This suggests momentum has cooled even as long term holders have seen solid gains. If MGIC’s recent...

A major US automaker’s decision to use Mobileye Global (MBLY) EyeQ6H chips for hands-free driving across millions of vehicles puts the company’s Surround ADAS technology at the center of evolving software-defined car platforms. See our latest analysis for Mobileye Global. Despite the new automaker deal and the planned Mentee Robotics acquisition, Mobileye’s share price return has been mixed, with a 30 day share price return of 3.34% but a 1 year total shareholder return decline of 26.99%,...

If you are wondering whether AbbVie’s current share price reflects its underlying value, you are not alone. This article will walk through what the market might be pricing in. AbbVie recently closed at US$220.04, with a 0.1% decline over 7 days, a 1.5% decline over 30 days, a 4.0% decline year to date, but a 28.9% return over 1 year, 58.4% over 3 years and 139.2% over 5 years, which may prompt questions about how much optimism or risk is already in the price. Recent headlines around AbbVie...